Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CMO | Ann: Appendix 4G | 19/09/24 | 0 | 1 | |||
|
|||||||
CMO | Ann: Corporate Governance Statement | 19/09/24 | 0 | 1 | |||
|
|||||||
CMO | Ann: Annual Report to shareholders | 19/09/24 | 0 | 1 | |||
|
|||||||
CMO | Ann: Change in director's interest | 22/03/19 | 0 | 26 | |||
|
|||||||
CMO | Ann: Result for the six months to 31 December 2018 | 20/02/19 | 0 | 97 | |||
|
|||||||
CMO | Ann: Transition to revised listing rules | 25/01/19 | 0 | 116 | |||
|
|||||||
CMO | Ann: Initial disclosure - Director's relevant interest | 03/12/18 | 0 | 179 | |||
|
|||||||
CMO | Ann: New director | 03/12/18 | 0 | 171 | |||
|
See All Discussions